Hypertension

Natural product-derived therapy for attenuating associated with Myocardial infarction: Formononetin, found  in Trifolium pratense and Maackia amurensis, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 18/November/2017, 8.19 am

Natural product-derived therapy for attenuating associated with Myocardial infarction: Formononetin, found  in Trifolium pratense and Maackia amurensis, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 18/November/2017, 8.19 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A recent study from Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; and Center for Systems Biology, Massachusetts General Hospital…

read more

Combinatorial therapy for Cardiac rejuvenation, diabetic-associated complications and Hypertension: A therapeutic mix encompassing  Aspirin and Fidarestat (AF) suppresses tumor suppressor INK4a/p16 expression, promotes cardiac repair, delays cardiac ageing and senescence, attenuates diabetic nephropathy, insulin resistance and hypertension and extends life span via up regulation of its target gene, 18/November/2017, 8.03 am

Combinatorial therapy for Cardiac rejuvenation, diabetic-associated complications and Hypertension: A therapeutic mix encompassing  Aspirin and Fidarestat (AF) suppresses tumor suppressor INK4a/p16 expression, promotes cardiac repair, delays cardiac ageing and senescence, attenuates diabetic nephropathy, insulin resistance and hypertension and extends life span via up regulation of its target gene, 18/November/2017, 8.03 am 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Combinatorial therapy for Cardiac rejuvenation, diabetic-associated complications and Hypertension: A therapeutic mix encompassing  Aspirin and Fidarestat (AF) suppresses tumor suppressor…

read more

Natural product therapy for pulmonary arterial hypertension:Mangiferin, isolated from Mangifera Indica, inhibits the development of pulmonary arterial hypertension via down regulation of  Notch3 and its target gene Hes5, 11/November/2017, 11.59 pm

Natural product therapy for pulmonary arterial hypertension:Mangiferin, isolated from Mangifera Indica, inhibits the development of pulmonary arterial hypertension via down regulation of  Notch3 and its target gene Hes5, 11/November/2017, 11.59 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General…

read more

Natural product therapy for pulmonary arterial hypertension: Tanshinone IIA, one of the main components of Salvia miltiorrhiza, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 29/October/2017, 7.40 am

Natural product therapy for pulmonary arterial hypertension: Tanshinone IIA, one of the main components of Salvia miltiorrhiza, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 29/October/2017, 7.40 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:   A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published, in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General…

read more

Molecular therapy for pulmonary arterial hypertension: Digoxin, commonly used in the treatment of heart failure and arrhythmias, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 22/October/2017, 1.05 am

Molecular therapy for pulmonary arterial hypertension: Digoxin, commonly used in the treatment of heart failure and arrhythmias, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 22/October/2017, 1.05 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.“ This study was published in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General…

read more

Natural product therapy for pulmonary arterial hypertension: A therapeutic mix encompassing Curcumin and Quercetin, isolated from Turmeric and Elder berries, respectively, inhibits the development of pulmonary arterial hypertension via down regulation of  Notch3 and its target gene Hes-5, 19/October/2017, 1.00 am

Natural product therapy for pulmonary arterial hypertension: A therapeutic mix encompassing Curcumin and Quercetin, isolated from Turmeric and Elder berries, respectively, inhibits the development of pulmonary arterial hypertension via down regulation of  Notch3 and its target gene Hes-5, 19/October/2017, 1.00 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General…

read more